These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17194738)

  • 1. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urocortin 2 induces tyrosine hydroxylase phosphorylation in PC12 cells.
    Nemoto T; Mano-Otagiri A; Shibasaki T
    Biochem Biophys Res Commun; 2005 May; 330(3):821-31. PubMed ID: 15809070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis.
    Dermitzaki E; Tsatsanis C; Gravanis A; Margioris AN
    J Cell Physiol; 2012 May; 227(5):1861-72. PubMed ID: 21702050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.
    Fukuda T; Takahashi K; Suzuki T; Saruta M; Watanabe M; Nakata T; Sasano H
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4671-8. PubMed ID: 15914529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
    Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
    Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
    Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
    Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortin stimulates tyrosine hydroxylase activity via the cAMP/protein kinase a pathway in rat Pheochromocytoma PC12 cells.
    Nanmoku T; Takekoshi K; Fukuda T; Isobe K; Shibuya S; Kawakami Y
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):124-7. PubMed ID: 15911134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
    J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
    Tasma Z; Wills P; Hay DL; Walker CS
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
    Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
    Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
    Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
    Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
    Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.